Total Payments
$8,302
2024 Payments
$583.42
Companies
35
Transactions
145
Medicare Patients
1,273
Medicare Billing
$198,777
Payment Breakdown by Category
Consulting$3,200 (38.5%)
Food & Beverage$3,164 (38.1%)
Research$1,184 (14.3%)
Travel$557.48 (6.7%)
Education$111.20 (1.3%)
Other$84.51 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,200 | 1 | 38.5% |
| Food and Beverage | $3,164 | 132 | 38.1% |
| Unspecified | $1,184 | 4 | 14.3% |
| Travel and Lodging | $557.48 | 3 | 6.7% |
| Education | $111.20 | 1 | 1.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $84.51 | 4 | 1.0% |
Payments by Type
General
$7,118
141 transactions
Research
$1,184
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,235 | 18 | $0 (2024) |
| SANOFI US SERVICES INC. | $1,142 | 3 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $507.63 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $349.44 | 17 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $203.87 | 5 | $0 (2024) |
| Allergan, Inc. | $194.98 | 4 | $0 (2021) |
| ACADIA Pharmaceuticals Inc | $188.10 | 9 | $0 (2024) |
| Abbott Laboratories | $140.83 | 1 | $0 (2022) |
| Merz Pharmaceuticals, LLC | $138.68 | 5 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $115.59 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $583.42 | 25 | Teva Pharmaceuticals USA, Inc. ($83.86) |
| 2023 | $534.34 | 28 | Teva Pharmaceuticals USA, Inc. ($127.02) |
| 2022 | $491.38 | 20 | Abbott Laboratories ($140.83) |
| 2021 | $397.04 | 21 | Novartis Pharmaceuticals Corporation ($98.82) |
| 2020 | $266.86 | 16 | MERZ NORTH AMERICA, INC. ($115.59) |
| 2019 | $159.54 | 8 | Acorda Therapeutics, Inc ($45.50) |
| 2018 | $4,684 | 22 | AbbVie, Inc. ($4,120) |
| 2017 | $1,185 | 5 | SANOFI US SERVICES INC. ($1,142) |
All Payment Transactions
145 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $37.91 | General |
| Category: Musculoskeletal | ||||||
| 12/05/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: AMANTADINE | ||||||
| 11/26/2024 | Merz Pharmaceuticals, LLC | AMPYRA (Drug) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: Multiple Sclerosis | ||||||
| 10/24/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/21/2024 | Cycle Pharmaceuticals Inc | Tascenso ODT (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: NEUROLOGY | ||||||
| 10/15/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Neurology | ||||||
| 10/14/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Immunology | ||||||
| 10/07/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: AMANTADINE | ||||||
| 09/23/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Neuroscience | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Neurology | ||||||
| 08/13/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Immunology | ||||||
| 07/31/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Neuropsychiatry | ||||||
| 07/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Central Nervous System | ||||||
| 07/15/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Immunology | ||||||
| 07/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: AMANTADINE | ||||||
| 06/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: Central Nervous System | ||||||
| 06/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: Central Nervous System | ||||||
| 05/13/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Neurology | ||||||
| 04/16/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: EPILEPSY | ||||||
| 04/08/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 01/22/2024 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug), KESIMPTA | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Neurology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Multicenter, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GZ/SAR402671 in Patients With Early-stage Parkinson's Disease | SANOFI US SERVICES INC. | $1,142 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 245 | 561 | $118,030 | $44,796 |
| 2022 | 4 | 223 | 466 | $94,705 | $35,034 |
| 2021 | 6 | 339 | 710 | $147,875 | $56,764 |
| 2020 | 7 | 466 | 974 | $203,997 | $62,184 |
Total Patients
1,273
Total Services
2,711
Medicare Billing
$198,777
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 160 | 412 | $78,692 | $30,334 | 38.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 44 | 61 | $16,470 | $7,076 | 43.0% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Facility | 2023 | 13 | 36 | $14,580 | $4,511 | 30.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 16 | 16 | $6,560 | $2,308 | 35.2% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2023 | 12 | 36 | $1,728 | $566.10 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 172 | 383 | $74,167 | $28,265 | 38.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 28 | 29 | $7,950 | $3,282 | 41.3% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Facility | 2022 | 11 | 28 | $11,340 | $3,148 | 27.8% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2022 | 12 | 26 | $1,248 | $338.21 | 27.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 243 | 564 | $107,724 | $42,984 | 39.9% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Facility | 2021 | 12 | 38 | $15,390 | $4,742 | 30.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 34 | 34 | $14,081 | $4,538 | 32.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 25 | 27 | $7,290 | $3,310 | 45.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2021 | 12 | 14 | $1,806 | $668.50 | 37.0% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Facility | 2021 | 13 | 33 | $1,584 | $520.80 | 32.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 285 | 716 | $142,803 | $42,576 | 29.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 69 | 69 | $28,380 | $9,551 | 33.7% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Facility | 2020 | 14 | 36 | $14,616 | $4,135 | 28.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 27 | 32 | $9,094 | $2,878 | 31.6% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Facility | 2020 | 45 | 72 | $5,472 | $1,937 | 35.4% |
| 99487 | Complex chronic care management services 60 minutes clinical staff time | Facility | 2020 | 12 | 16 | $2,016 | $689.17 | 34.2% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Facility | 2020 | 14 | 33 | $1,616 | $418.25 | 25.9% |
About Dr. Alida Griffith, MD
Dr. Alida Griffith, MD is a Neurology healthcare provider based in Kirkland, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1861474793.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alida Griffith, MD has received a total of $8,302 in payments from pharmaceutical and medical device companies, with $583.42 received in 2024. These payments were reported across 145 transactions from 35 companies. The most common payment nature is "Consulting Fee" ($3,200).
As a Medicare-enrolled provider, Griffith has provided services to 1,273 Medicare beneficiaries, totaling 2,711 services with total Medicare billing of $198,777. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Kirkland, WA
- Active Since 11/16/2005
- Last Updated 01/27/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1861474793
Products in Payments
- Duopa (Drug) $4,097
- GZ402671 (Drug) $1,142
- KESIMPTA (Drug) $279.37
- BOTOX (Biological) $252.29
- NUPLAZID (Drug) $188.10
- Austedo XR (Drug) $172.82
- AUSTEDO (Drug) $166.22
- INFINITY (Device) $140.83
- XEOMIN (Biological) $115.59
- Xeomin (Biological) $107.53
- ZEPOSIA (Drug) $89.65
- INBRIJA (Drug) $82.50
- INGREZZA (Drug) $78.03
- BRIUMVI (Drug) $74.81
- ACTIVA (Device) $71.32
- MAYZENT (Drug) $70.07
- VALTOCO (Drug) $60.00
- RYTARY (Drug) $58.51
- Gocovri (Drug) $47.75
- Briviact (Drug) $46.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Kirkland
Dr. Jason Poon, M.d, M.D
Neurology — Payments: $97,966
Neurology $97,966
Dr. Arash Fazl, M.d. , Ph.d, M.D. , PH.D
Neurology — Payments: $39,994
Neurology $39,994
James Song, M.d, M.D
Neurology — Payments: $30,735
Neurology $30,735
Dr. Zeyad Morcos, Md, MD
Neurology — Payments: $14,243
Neurology $14,243
Dr. Casey Nazor, M.d, M.D
Neurology — Payments: $8,976
Neurology $8,976
Dr. Daniel Burdick, Md, MD
Neurology — Payments: $6,269
Neurology $6,269